General - Press Releases

Date	Title	Company
03-Oct-2023	Athersys Licenses its Animal Health Assets to Ardent Animal Health	Businesswire
03-Oct-2023	Insulet Announces CFO Transition	Businesswire
03-Oct-2023	Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer	Businesswire
03-Oct-2023	Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs	Businesswire
03-Oct-2023	MedinCell and the European Investment Bank (EIB) Have Replaced a Financial Covenant of Their Ongoing Loan Agreement to Better Fit with MedinCell Business Model	Businesswire
03-Oct-2023	Beaconcure Technologies Welcomes Additions to Leadership Team	Businesswire
03-Oct-2023	ZS Announces Launch of ZAIDYN™ Connected Health	Businesswire
03-Oct-2023	Synchrony Symposium 2023 Advances Research and Clinical Care for Neurodevelopmental Disorders, Including Autism	Businesswire
03-Oct-2023	Información actualizada de Takeda sobre EXKIVITY® (mobocertinib)	Businesswire
03-Oct-2023	A New Publication Highlights the Use of cResponse in the Assessment of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer	Newswire
03-Oct-2023	Pharma Logistics Awarded Department of Defense Contract for Pharmaceutical Reverse Distribution Services	Businesswire
03-Oct-2023	Saghmos Therapeutics Announces Appointment of Pharmaceutical Industry Veteran Fred Hassan as Chairman of the Board of Directors	Businesswire
03-Oct-2023	Intensifying Competition and Regulatory Demands Fuel Growth: Global Medical Device Analytical Testing Outsourcing Market Poised to Reach $10.57 Billion by 2030 - ResearchAndMarkets.com	Businesswire
03-Oct-2023	Coya Therapeutics Announces the Presentation of Human Ex-Vivo Mechanistic Data Further Supporting the Development of COYA 302 for Amyotrophic Lateral Sclerosis (ALS) at the 22nd Annual Northeast ALS (NEALS) Consortium Meeting	Businesswire
03-Oct-2023	AKEEGA™ (niraparib and abiraterone acetate) Now Available from Onco360	Businesswire
03-Oct-2023	Pinnacle Treatment Centers Taps Michael Lawler as New CEO	Businesswire
03-Oct-2023	Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable	Businesswire
03-Oct-2023	HighVista Strategies LLC Completes Acquisition of abrdn’s U.S. Private Markets Business	Businesswire
03-Oct-2023	InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical Executive, Mark Levick, MD, Ph.D. as New Board Director	Businesswire
03-Oct-2023	Gilead to Present Latest Innovative Virology Data on Current and Potentially Transformative Therapies Across HIV and COVID-19 at IDWeek 2023	Businesswire